Veracyte Inc VCYT:NASDAQ

Last Price$30.15Cboe Previous Close - Real-Time Last Sale as of 3:59PM ET 1/17/20
Cboe Real-Time Quotes
Today's Change0(0.00%)
Bid (Size)$28.94 (100)
Ask (Size)$31.99 (100)
Day Low / HighN/A - N/A
Volume345.0 K
  • Latest Stories
  • Commentary and Analysis
Insider Trends: Insider Sales Extend 90-Day Trend at Veracyte
4:56PM ET 1/15/2020 MT Newswires

On Jan 14, 2020, Director, Evan Jones, executed a sale of 5,000 shares in Veracyte (VCYT) for $142,521. After the Form 4 filing with the SEC, Jones...

Veracyte, AstraZeneca's Acerta Pharma Pursue Collaboration
8:48AM ET 1/08/2020 MT Newswires

Veracyte (VCYT) said pre-market Wednesday that it has entered into a multi-year collaboration with Acerta Pharma, the hematology research and development...

Insider Trends: Insider Prolongs 90-Day Selling Trend at Veracyte
4:39PM ET 12/18/2019 MT Newswires

Evan Jones, Director, reported a sale of 15,000 shares in Veracyte (VCYT) on Dec 17, 2019, for $438,866. Following the Form 4 filing with the SEC, Jones...

Insider Trends: Insider Sale Eases Back 90-Day Buy Trend at Veracyte
4:21PM ET 12/09/2019 MT Newswires

Evan Jones, Director, on Dec 05, 2019, sold 5,951 shares in Veracyte (VCYT) for $178,558. Jones, subsequent to the transactions disclosed in the SEC Form...

Insider Trends: Insider at Veracyte Converts/Exercises Derivative Security, Sells for Taxes and Self, Buying Trend Remains Intact
4:24PM ET 12/04/2019 MT Newswires

On Dec 02, 2019, Chief Scientific & Med Officer, Dr Giulia C Kennedy, exercised options/derivative securities for 15,032 shares. A portion of these...

Veracyte Buys NanoString nCounter Platform for Diagnostic Use for $50 Million in Cash and Stock Deal
5:16PM ET 12/03/2019 MT Newswires

Veracyte (VCYT) said on Tuesday it has acquired an exclusive global license to NanoString's (NSTG) nCounter platform for diagnostic use to expand its...

Veracyte Q3 Results Beat Expectations
5:07PM ET 10/22/2019 MT Newswires

Veracyte (VCYT) on Tuesday reported a $0.02 loss per share for Q3, down from $0.12 loss per share in the year-ago period, beating Capital IQ estimate of...

Veracyte's Noninvasive Nasal Swab Test Shows Accurate Classification of Lung Cancer Risk in Patients With Lung Nodules
3:15PM ET 10/22/2019 MT Newswires

Veracyte (VCYT) said Tuesday its noninvasive nasal swab test's preliminary clinical data showed an accurate classification of lung cancer risk in patients...

MT Newswires After-Hours News Movers
5:54PM ET 10/21/2019 MT Newswires

Some of the stocks moving on news-driven events in Monday's after-hours include: NLNK, +7.38% AMTD, +5.31% CDNS, +4.84% WSFS, +1.79% UPS, +1.58% ZION,...

Veracyte's Data Shows Validity and Utility of Percepta Classifier in Lung Cancer Diagnosis
5:11PM ET 10/21/2019 MT Newswires

Veracyte (VCYT) said on Monday data showed the clinical validity of its next-generation Percepta Genomic Sequencing Classifier (GSC) and the clinical...